Chapter
Psilocybin vs. Lexapro for depression treatment
49:47 - 54:02 (04:15)
A head-to-head clinical trial compared the efficacy of psilocybin, a molecule found in magic mushrooms, with the well-known antidepressant Lexapro for treating major depressive disorder. Patients in the psilocybin group received two doses of 25 milligrams spaced three weeks apart, while the Lexapro group received a standard SSRI dose.
Clips
The effectiveness of pure synthetic psilocybin compared to top tier SSRIs in treating depression was tested in a recent study.
49:47 - 51:20 (01:33)
Summary
The effectiveness of pure synthetic psilocybin compared to top tier SSRIs in treating depression was tested in a recent study. However, the results may have been misinterpreted.
ChapterPsilocybin vs. Lexapro for depression treatment
Episode#517: Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and the 3 Most Important Levers to Pull
PodcastThe Tim Ferriss Show
This study is a head-to-head comparison of the use of psilocybin and Lexapro, a common SSRI, for major depressive disorder.
51:20 - 54:02 (02:42)
Summary
This study is a head-to-head comparison of the use of psilocybin and Lexapro, a common SSRI, for major depressive disorder. Patients who received psilocybin received two doses spaced out three weeks apart, while the study is notable for its comparison with nuanced protocols.